Mirae Asset Global Investments Co. Ltd. Boosts Holdings in Oscar Health, Inc. (NYSE:OSCR)

Mirae Asset Global Investments Co. Ltd. grew its position in Oscar Health, Inc. (NYSE:OSCR) by 270.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 265,031 shares of the company’s stock after purchasing an additional 193,512 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Oscar Health were worth $2,425,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in OSCR. Envestnet Asset Management Inc. purchased a new stake in shares of Oscar Health in the 1st quarter valued at approximately $164,000. Advisor Group Holdings Inc. grew its stake in shares of Oscar Health by 157.5% in the 1st quarter. Advisor Group Holdings Inc. now owns 10,106 shares of the company’s stock valued at $101,000 after buying an additional 6,182 shares during the period. Swiss National Bank grew its stake in shares of Oscar Health by 8.6% in the 1st quarter. Swiss National Bank now owns 103,100 shares of the company’s stock valued at $1,028,000 after buying an additional 8,200 shares during the period. Ergoteles LLC purchased a new stake in shares of Oscar Health in the 1st quarter valued at approximately $633,000. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Oscar Health by 2.5% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 193,504 shares of the company’s stock valued at $1,930,000 after buying an additional 4,801 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Performance

Shares of OSCR stock opened at $16.44 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.37. Oscar Health, Inc. has a 52 week low of $4.72 and a 52 week high of $18.55. The stock has a market capitalization of $3.78 billion, a PE ratio of -13.70 and a beta of 1.79. The firm has a 50 day moving average of $15.28 and a two-hundred day moving average of $10.75.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) EPS for the quarter, beating the consensus estimate of ($0.74) by $0.08. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The company had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter last year, the company posted ($1.05) EPS. The firm’s revenue was up 43.9% compared to the same quarter last year. On average, research analysts predict that Oscar Health, Inc. will post -0.23 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. The Goldman Sachs Group increased their price objective on shares of Oscar Health from $8.00 to $16.00 and gave the stock a “neutral” rating in a research report on Friday, February 9th. TheStreet raised shares of Oscar Health from a “d” rating to a “c-” rating in a research report on Wednesday, February 21st. Wells Fargo & Company increased their price objective on shares of Oscar Health from $12.00 to $20.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. Finally, Raymond James assumed coverage on shares of Oscar Health in a research report on Friday, March 22nd. They set an “outperform” rating and a $20.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $13.50.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.